Huebner J, Rack-Hoch A L, Pecar A, Schmid I, Klein C, Borde J P
Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital, Ludwig-Maximilians-Universität München.
Klin Padiatr. 2013 Jul;225(4):223-9. doi: 10.1055/s-0033-1349063. Epub 2013 Jul 12.
The steady increase in antimicrobial resistance is of growing concern in healthcare. Antibiotic Stewardship [ABS] Strategies are important tools to control antibiotic use and -prevent antimicrobial resistance. An increasing number of institutions are developing ABS initiatives also in pediatrics. However, few data are available assessing the implementation and efficiency of these pediatric ABS programs.At the Dr. von Hauner Children's Hospital, Ludwig-Maximilian University, a tertiary care pediatric reference center, a pediatric ABS Team has been implemented. Key structural elements were the same as for adult patients, but antimicrobials agents selected for monitoring and appropriate clinical endpoints are different in pediatrics.Key features were: 1. prospective-audit with feedback and formulary restriction and 2. pre-authorization (also referred to as prior approval). The ABS team consisted of one pediatric infectious disease specialist, one clinical fellow in pediatric infectious diseases, and one clinical pharmacist with training in infectious diseases.With the implementation of a pediatric ABS strategy we could significantly influence antimicrobial consumption in our hospital. Cost-savings are estimated to be above 330 000 € per year, and concomitantly the use of broad-spectrum antibiotics and antifungal compounds was significantly reduced.Antibiotic Stewardship [ABS] Strategies may be an effective tool to control antibiotic use in the setting of a large tertiary pediatric teaching hospital. A national guideline for ABS initiatives may help to further improve rational use of antibiotics in the hospital setting.
抗菌药物耐药性的稳步上升在医疗保健领域日益受到关注。抗生素管理(ABS)策略是控制抗生素使用和预防抗菌药物耐药性的重要工具。越来越多的机构也在儿科开展ABS倡议。然而,评估这些儿科ABS项目实施情况和效率的数据却很少。在路德维希 - 马克西米利安大学冯·豪纳儿童医院(一家三级儿科转诊中心),已实施了一个儿科ABS团队。关键结构要素与成人患者相同,但儿科中选择用于监测的抗菌药物和适当的临床终点有所不同。
通过实施儿科ABS策略,我们能够显著影响我院的抗菌药物使用情况。估计每年节省成本超过33万欧元,同时广谱抗生素和抗真菌化合物的使用也显著减少。
抗生素管理(ABS)策略可能是在大型三级儿科教学医院环境中控制抗生素使用的有效工具。ABS倡议的国家指南可能有助于进一步改善医院环境中抗生素的合理使用。